SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Cantor Fitzgerald Reiterates Overweight on Novavax, Raises Price Target to $45

Cantor Fitzgerald reiterates Novavax (NASDAQ:NVAX) with a Overweight and raises the price target from $23 to $45.

Benzinga · 05/13/2020 10:44

Cantor Fitzgerald reiterates Novavax (NASDAQ:NVAX) with a Overweight and raises the price target from $23 to $45.